Japan, March 3 -- IMCHECK THERAPEUTICS SAS,INSERM (INST NAT SANTE RECH MED),UNIV AIX MARSEILLE,INSTITUT JEAN PAOLI & IRENE CALMETTES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE has got intellectual property rights for 'ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS.' Other related details are as follows:
Application Number: JP,2023-204480
Category (FI): A61K38/20,A61K39/395@D,A61K39/395@N,A61P35/00,A61P37/04,A61P43/00,105,A61P43/00,121,C07K16/28,C07K16/46
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 4, 2023
Publication Date: March 5, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
